HealthLynked Corp. (HLYK)
OTCMKTS · Delayed Price · Currency is USD
2.283
+0.067 (3.04%)
At close: May 29, 2026
HealthLynked Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1.7 | 2.04 | 2.98 | 5.66 | 5.84 | 6.48 |
Other Revenue | 0.02 | 0.02 | 0.03 | 0.06 | 0.02 | 0.01 |
| 1.71 | 2.07 | 3.01 | 5.72 | 5.86 | 6.5 | |
Revenue Growth (YoY) | -38.29% | -31.35% | -47.43% | -2.32% | -9.83% | 21.09% |
Cost of Revenue | 0.8 | 1.07 | 2.09 | 3.37 | 3.8 | 3.72 |
Gross Profit | 0.92 | 1 | 0.92 | 2.35 | 2.06 | 2.78 |
Selling, General & Admin | 2.25 | 2.04 | 3.04 | 3.62 | 4.58 | 4.93 |
Other Operating Expenses | 0.76 | 0.97 | 1.56 | 2.21 | 2.57 | 2.35 |
Operating Expenses | 3.11 | 3.11 | 4.88 | 6.18 | 7.97 | 8.11 |
Operating Income | -2.2 | -2.11 | -3.96 | -3.83 | -5.91 | -5.33 |
Interest Expense | -0.67 | -1.04 | -1.48 | -0.5 | -0.08 | -0.02 |
Other Non Operating Income (Expenses) | -0 | 0.01 | - | - | -0.11 | - |
EBT Excluding Unusual Items | -2.87 | -3.15 | -5.45 | -4.33 | -6.1 | -5.35 |
Impairment of Goodwill | - | - | - | -0.32 | - | - |
Gain (Loss) on Sale of Assets | 0.17 | 0.17 | - | - | - | - |
Asset Writedown | - | - | -0.72 | - | -2.75 | - |
Other Unusual Items | -1.15 | -0.3 | 0.03 | 1.04 | 0.78 | -5.35 |
Pretax Income | -3.85 | -3.28 | -6.13 | -3.61 | -8.07 | -10.7 |
Earnings From Continuing Operations | -3.85 | -3.28 | -6.13 | -3.61 | -8.07 | -10.7 |
Earnings From Discontinued Operations | - | - | - | 2.6 | -0.75 | 0.29 |
Net Income | -3.85 | -3.28 | -6.13 | -1.01 | -8.82 | -10.41 |
Preferred Dividends & Other Adjustments | 0.04 | - | - | - | 0.35 | 0.35 |
Net Income to Common | -3.89 | -3.28 | -6.13 | -1.01 | -9.17 | -10.77 |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 2 | 2 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 2 | 2 |
Shares Change (YoY) | 1.32% | 0.72% | 7.09% | 8.00% | 8.35% | 57.30% |
EPS (Basic) | -1.36 | -1.16 | -2.18 | -0.39 | -3.77 | -4.79 |
EPS (Diluted) | -1.37 | -1.16 | -2.18 | -0.39 | -3.77 | -4.87 |
Free Cash Flow | -1.5 | -1.71 | -3.5 | -4.15 | -4.39 | -3.79 |
Free Cash Flow Per Share | -0.53 | -0.60 | -1.24 | -1.58 | -1.80 | -1.69 |
Gross Margin | 53.40% | 48.28% | 30.48% | 41.05% | 35.15% | 42.72% |
Operating Margin | -128.12% | -102.32% | -131.69% | -66.96% | -100.95% | -82.05% |
Profit Margin | -226.70% | -158.83% | -203.81% | -17.69% | -156.52% | -165.71% |
Free Cash Flow Margin | -87.67% | -82.98% | -116.23% | -72.46% | -74.88% | -58.32% |
EBITDA | -2.1 | -2.01 | -3.85 | -3.71 | -5.08 | -4.5 |
EBITDA Margin | -122.29% | -97.39% | -127.86% | -64.80% | -86.79% | -69.31% |
D&A For EBITDA | 0.1 | 0.1 | 0.12 | 0.12 | 0.83 | 0.83 |
EBIT | -2.2 | -2.11 | -3.96 | -3.83 | -5.91 | -5.33 |
EBIT Margin | -128.12% | -102.32% | -131.69% | -66.96% | -100.95% | -82.05% |
Revenue as Reported | 1.71 | 2.07 | 3.01 | 5.72 | 5.86 | 6.5 |